Lilly Schizo Drug Strikes Out; 115 New Jobs for Boehringer - Aug. 29, 2012

Having trouble viewing this email? View in Browser.

Wednesday, August 29, 2012  |   |   |   |  Pharm-Olam has offices among the most populated cities in Europe, Latin America, India, South Africa, and the USA to provide for oncology studies of all sizes. Pharm-Olam has helped bring 2 oncology compounds to NDA approval and have conducted oncology studies in over 30 countries. Our Executive VP of Clinical Development will speak at the 5th annual Oncology Clinical Trials in Emerging Regions conference in Morristown, NJ October 22-23. Sponsors can visit the Pharm-Olam website to obtain a 20% discount code. The incidence of oncology indications and standards of treatment can vary widely, so let Pharm-Olam conduct a complimentary feasibility study specific to your protocol and study budgets to use in your resource planning. Contact us at www.pharm-olam.com, info@pharm-olam.com, USA 1-713-559-7900, UK 44-0-1344 891121.   •  Eli Lilly and Company (LLY) Schizo Drug Strikes Out More... •  115 New Jobs for Boehringer Ingelheim Vetmedica, Inc. More... •  Achillion Pharmaceuticals, Inc. (ACHN) Re-emerges as Takeover Target as Hepatitis Drugs Fail More... •  SEC Charges 8 With Insider Trading in Sanofi (France) (SAN.PA) Deal More... •  FDA Backs Approval of Abbott Laboratories (ABT)'s Humira for New Use More... •  Bayer AG (BAY.F) Says Blood Thinner Cuts Risk of Repeat Heart Attack More... •  ArQule, Inc. (ARQL) Plunges as Japanese Partner Temporarily Suspends Tivantinib Trial; Stock Down -1.74(25.97%) 10:11AM EDT More... •  Novartis AG (NVS): "We Do Not Bribe Anyone" More... More Top News JAX® In Vivo Pharmacology Services Rely on our unmatched expertise in efficacy studies to accelerate your drug discovery research. Our in vivo pharmacology testing services are fast, flexible, and supported by our 80-year history in mouse-based research. We provide comprehensive, data-driven efficacy testing in a wide range of therapeutic areas: • Oncology • Inflammatory and autoimmune disease • Metabolic disorders • Neuromuscular and neurodegenerative disorders To date, we have performed in vivo studies in over 100 mouse strains, We work closely with you to ensure that any custom protocols are executed to your exact specifications, and have documented success in implementing conventional protocols and adapting the latest procedures from the literature. Please click here for more information. •  Gene That Predicts Happiness in Women Discovered, University of South Florida Study More... •  Aspirin May Help Men With Prostate Cancer Live Longer, UT Southwestern Medical Center Study More... •  Softer Fast Food Restaurant Lighting and Music Can Cut Calorie Intake 18 Percent, Cornell University Study More... •  Tuning a Piano "Moulds the Mind," University College London and Newcastle University Study More... •  Protein Found to Regulate Red Blood Cell Size and Number, Massachusetts Institute of Technology (MIT) Study More... •  Metabolism in the Brain Fluctuates With Circadian Rhythm, University of Illinois Study More... •  Better Vaccines for Tuberculosis Could Save Millions of Lives, Trends in Molecular Medicine Reveals More... •  Which Drugmakers Are Feeding The Republicans? More...   More Featured News The new post-Master's Graduate Certificate in Sequence Analysis and Genomics at Johns Hopkins University has been endorsed by the Maryland Higher Education Commission (MHEC) and is officially accepting applications for Fall 2012 and beyond. Fall, Spring and Summer admission is available to eligible applicants. The new certificate is targeted at scientists who already have grounding in biochemistry, molecular biology and cell biology but need the bioinformatics skills to design experiments and analyze data. The program introduces students to the foundations of bioinformatics through the core bioinformatics courses and then the students take upper level courses that are required for understanding and performing sequence and genomic analysis. This program will be offered online and onsite. Please click here for more information. Contact Information: Beatrice Kondo Program Coordinator bkondo@jhu.edu Kris Obom Program Director kobom@jhu.edu • Genetown (Cambridge, Massachusetts) Vertex Associate Director, Clinical Pharmacology Assisting the planning and execution of the Clinical Development Plan for new clinical entities particularly as it applies to the discipline of Clinical Pharmacology. The AD will supervise or conduct clinical studies such as drug-drug interaction, special population or bioavailability, working with Vertex teams. • Genetown (Cambridge, Massachusetts) Vertex Director, Clinical Pharmacology Assisting the planning and execution of the Clinical Development Plan for new clinical entities particularly as it applies to the discipline of Clinical Pharmacology. The Director will supervise or conduct clinical studies such as drug-drug interaction, special population or bioavailability, working with Vertex teams. • Pharm Country (Summit, New Jersey) Celgene Scientist II Will be responsible for well-defined and controlled experiments being mindful of translational relevance. Responsible for experimental design, interpretation of results and making scientific presentations to global project teams and senior management. • Biotech Beach (Santa Monica, California) Astellas Pharma US QC Microbiologist Supervisor Supervise staff, product testing and Environmental Monitoring data within the QC Microbiology department in support of clinical manufacturing. The role will act as a technical expert within the organization with extensive knowledge related to aseptic procedure and compendial testing. • BioMidwest (Chicago, Illinois) Takeda Pharmaceuticals Quality Systems Program Manager Provide a regional resource to lead TGRD US functional teams in the identification and mitigation of systemic issues which may compromise the compliance of Takeda's drug development operations. The person in this position will work with PDD Global Quality Assurance and TGRD US project teams in the quality investigation, deviation and waiver process including root cause analysis, remediation, tracking and documentation. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! 2012 Pharm Country Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the tri-state area. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Pharm Country Career Fair, Bridgewater, NJ September 13, 2012 • Biotech Beach Career Fair, San Diego, CA September 20, 2012 • Biotech Bay Career Fair, Burlingame, CA October 3, 2012 • BioCapital Career Fair, Bethesda, MD October 9, 2012 • BioMidwest Career Fair, Lincolnshire, IL October 22, 2012 • Bio NC Career Fair, Durham, NC October 25, 2012 • Genetown Career Fair, Cambridge, MA November 5, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 • Evaluate the PFC market in terms of regulatory environment, demand/supply dynamics, market size and structure. •Gain up-to-date information regarding the deals and alliances in the PFC industry and how they affect the major players in this market. • Understand the basic PFC manufacturing processes and the raw materials used in their production. Click Here for More Information. Amicus Therapeutics, Inc. 1 Cedar Brook Drive Cranbury, New Jersey 08512 U.S.A. Phone: 609-662-2000 Fax: 609-662-2807 Amicus Therapeutics is a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases. The Company is developing novel, first-in-class, small molecules called pharmacological chaperones, to treat human genetic diseases, including lysosomal storage diseases. More Company Profiles FREE Subscription to Drug Discovery & Development Drug Discovery & Development magazine delivers vital insight about the latest technologies and tools used to develop pharmaceutical products in a way that no other publication can to key decision-makers. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Lana Ho Editorial & Production Staff: Maysa Darwish, Tammy Liu BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.